Search clinical trials for: Ixazomib (MLN9708)
Total 170 results
-
Millennium Pharmaceuticals, Inc.CompletedFollicular LymphomaUnited States, United Kingdom, Belgium, Canada
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | High Risk Smoldering Multiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Poland, Greece, Australia, Sweden
-
Northside Hospital, Inc.Millennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | Acute Leukemia | Myelodysplastic Syndrome | Lymphomas | Chronic LeukemiaUnited States
-
National Cancer Institute (NCI)WithdrawnMultiple Myeloma
-
Millennium Pharmaceuticals, Inc.TerminatedRelapsed or Refractory Systemic Light Chain AmyloidosisUnited States, Canada, Spain, Israel, France, Australia, Denmark, Germany, Korea, Republic of, Greece, Netherlands, Brazil, Czechia, Italy, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, France, Korea, Republic of, Canada, Belgium, New Zealand, Russian Federation
-
Steven E. CoutreNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
Jason ValentCompletedMultiple Myeloma | Kahler Disease | Myelomatosis | Plasma-Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedAdvanced CancersUnited States
-
Emory UniversityTakedaCompleted
-
Dartmouth-Hitchcock Medical CenterTerminatedBreast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterWithdrawnNeoplasms | LymphomaUnited States
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Parameswaran HariCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterMillennium: The Takeda Oncology CompanyTerminated
-
National Cancer Institute (NCI)Recruiting
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and Refractory Multiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | Advanced Solid TumorsUnited States, Canada
-
University of Michigan Rogel Cancer CenterCompletedLymphoma, T-CellUnited States
-
Mehdi HamadaniCompletedAllogeneic Hematopoietic Stem Cell TransplantationUnited States
-
Millennium Pharmaceuticals, Inc.WithdrawnPrecursor Cell Lymphoblastic Leukemia-lymphomaSpain, United States
-
ICOS-Texas BiotechnologyICOS Corporation; Texas Biotechnology CorporationUnknownPulmonary HypertensionUnited States, Canada
-
TakedaTerminatedLupus NephritisUnited States, France, United Kingdom, Germany, Spain, Russian Federation, Italy
-
Arbeitsgemeinschaft medikamentoese TumortherapieTakedaTerminatedTriple-Negative Breast CancerAustria
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLymphoma | Multiple Myeloma | AmyloidosisUnited States, China, Belgium, Canada, Poland, Spain, Korea, Republic of, Greece, Singapore, Japan, Sweden
-
TakedaCompletedRelapsed/Refractory Multiple MyelomaJapan
-
M.D. Anderson Cancer CenterMillennium: The Takeda Oncology CompanyCompleted
-
TakedaActive, not recruitingMultiple Myeloma | Autologous Stem Cell TransplantUnited States, Spain, Australia, Czechia, Hungary, Taiwan, Italy, Denmark, Portugal, Singapore, Israel, Canada, France, Belgium, United Kingdom, Germany, Japan, Austria, Netherlands, Korea, Republic of, Poland, Greece, Colombia, Sweden, South Africa and more
-
Millennium Pharmaceuticals, Inc.Completed
-
Nantes University HospitalCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; CelgeneCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationActive, not recruitingPlasma Cell Myeloma | Residual DiseaseUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI)Recruiting
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); Millennium...Active, not recruitingMantle Cell LymphomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedLight-Chain AmyloidosisUnited States, Canada, France, Germany, Italy
-
National Cancer Institute (NCI)CompletedRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPlasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
Fred Hutchinson Cancer CenterActive, not recruitingPlasma Cell Myeloma | Transplant-Related CarcinomaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); National Marrow Donor Program; Blood and Marrow...CompletedMultiple MyelomaUnited States
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.; Multiple Myeloma Research ConsortiumActive, not recruiting
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingWaldenstrom Macroglobulinemia | Recurrent Waldenstrom Macroglobulinemia | Refractory Waldenstrom MacroglobulinemiaUnited States